insights_auto
Why is DRUG down 4.02%?
Dive Deeperchevron_right
DRUG:CNSX
Bright Minds Biosciences Inc
CA$74.00
arrow_downward
-4.02%(-3.10) 1D
Oct 13, 1:46:17 PM GMT-4 · CAD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DRUG...
Open
CA$77.31
High
CA$77.31
Low
CA$73.97
Mkt. cap
729.94M
Avg. vol.
845.00
Volume
645.00
52-wk high
CA$170.00
52-wk low
CA$68.02
EPS
-CA$2.90
No. of employees
26
Open
CA$77.31
High
CA$77.31
Low
CA$73.97
Mkt. cap
729.94M
Avg. vol.
845.00
Volume
645.00
52-wk high
CA$170.00
52-wk low
CA$68.02
EPS
-CA$2.90
No. of employees
26
News stories
From web sources and news partners
FXStreet
·
8 minutes ago
S&P 500 earnings just hit a record. The AI data centre bill hasn't landed yet
ChartMill
·
26 minutes ago
What's going on in today's session: S&P500 most active stocks
The Economic Times
·
30 minutes ago
Could the US stock market crash in October? What are the Dow Jones, S&P 500 and Nasdaq showing? Here’s wha
Yahoo Finance
·
1 hour ago
Warren Buffett's Simple Way To Build Wealth With the S&P 500
Profile
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
About Bright Minds Biosciences Inc